Recombinant Mouse DAPK3 Protein，His

DAPK3, or Death-Associated Protein Kinase 3, is a serine/threonine kinase that plays a significant role in various cellular processes, including apoptosis, autophagy, and cell differentiation. Its dysregulation has been implicated in several pathological conditions, such as cancer and neurodegenerative diseases, making it a target of interest for therapeutic development. Research has shown that DAPK3 can modulate signaling pathways associated with cell survival and death, suggesting its potential as a biomarker for disease progression and treatment response. Recent advancements in recombinant protein technology have enabled the production of DAPK3 in a more stable and active form, facilitating in-depth structural and functional studies. These studies aim to elucidate the mechanisms by which DAPK3 exerts its effects within the cell, identify potential interacting proteins, and explore its post-translational modifications. Understanding the biological role of DAPK3 through recombinant protein studies is crucial for developing novel therapeutic strategies that can mitigate its aberrant activity in diseases. As researchers continue to investigate the functional implications of DAPK3, it holds promise for contributing to the development of targeted therapies, ultimately improving patient outcomes in disorders where this kinase plays a critical role.